Abstract
Background: COVID-19 represents an unprecedented challenge to the world. Various attempts have been made to overcome COVID-19, including employing multiple drug therapies. Objective: This study was conducted to describe the drug therapy of COVID-19 inpatients at the West Nusa Tenggara Hospital in 2020. Methods: Observation of 102 patients was conducted retrospectively. Data collection was performed by analysing medical records. Results: A total of 62 out of the 102 patients (60.8%) were hospitalised more than four weeks. 57 patients (55.9%) received antivirus therapy with Oseltamivir and 47 patients (46.1%) recieved azithromycin as adjuvant antibiotic therapy. Most of the patients (63.7%) received vitamin C as an immunomodulator. A small number of patients received other supportive therapies recommended to decrease the symptoms of COVID-19. The most frequent administered therapies for COVID-19 patients hospitalised at the West Nusa Tenggara Hospital are antivirals, antibiotics, and immunomodulatory. Conclusion: The findings provide an overview of therapy use for COVID-19 inpatients in West Nusa Tenggara Hospital. There is a need to assess the effectiveness of the therapy to promote safe and effective use of drugs for COVID-19 patients in the future.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
